Overview
Disease Type
ER Status
PR Status
HER2 Status
Loading...
Oncoplot
Loading...
Loading...
Scatterplot of Two main Principal Components
Click on legend to highlight trace
Scatterplot of Three main Principal Components
Loading...
Box Plot
Bar Plot
Find similar donors in BCNB
The Breast Cancer Now Biobank (BCNB) holds tissue, blood and cell samples, with linked clinical data, from donors across the UK. Use the BCNB Cohort Browser to identify donors with clinical characteristics similar to those selected in your analysis and explore the samples and data available for them.
Where matching filters exist, your current clinical selection criteria will automatically be carried over to the Cohort Browser (age, sex, survival status, menopausal status, family history, grade, diagnosis, ethnicity and ER/PR/HER2 status). Filters without a corresponding match will not be applied. You can further refine your selection within the Cohort Browser.
Filters carried over:
No matching filters selected: all BCNB donors will be shown.
Open Cohort Browser
Opens in a new tab, so your analysis here is kept.
To request samples and/or data, submit an Expression of Interest (EOI) form through the BCNB Request System.
For specific queries, visit Need Help? to contact the relevant BCNB team.
- Each row is a donor from the Cancer Cell Line Encyclopedia project.
- Every donor has cell line data, so the genomics results count the same donors as the table.
| Cell line | Age at Diagnosis | Sex Assigned at Birth | Population | Cell type | ER | PR | HER2 | Tissue | Disease |
|---|---|---|---|---|---|---|---|---|---|
| AU565 | 43.0 | female | White | NA | negative | negative | positive | derived from metastitic site:malignant pleural effusion | adenocarcinoma |
| BT20 | 74.0 | female | White | epithelial | negative | negative | negative | breast | carcinoma |
| BT474 | 60.0 | female | White | epithelial | positive | positive | positive | breast;duct | ductal carcinoma |
| BT483 | 23.0 | female | White | epithelial | positive | positive | negative | breast | ductal carcinoma |
| BT549 | 72.0 | female | White | epithelial | negative | negative | negative | breast | ductal carcinoma |
| CAL120 | 43.0 | female | NA | NA | negative | negative | negative | derived from metastatic site:pleural effusion | adenocarcinoma |
| CAL148 | 58.0 | female | NA | NA | negative | negative | negative | derived from metastatic site:pleural effusion | ductal carcinoma |
| CAL51 | 45.0 | female | NA | NA | negative | negative | negative | derived from metastatic site:pleural effusion | carcinoma |
| CAL851 | 35.0 | female | NA | NA | negative | negative | negative | primary | galactophoric breast adenocarcinoma |
| CAMA1 | 51.0 | female | White | epithelial | positive | discordant | negative | derived from metastatic site:pleural effusion | adenocarcinoma |
| COLO824 | 52.0 | female | African American | NA | negative | negative | weakly positive | derived from metastatic site:pleural effusion | carcinoma |
| DU4475 | 70.0 | female | White | carcinoma;skin | negative | negative | negative | derived from metastatic site:skin carcinoma | NA |
| EFM19 | 50.0 | female | White | NA | positive | positive | negative | derived from metastatic site:pleural effusion | ductal carcinoma |
| EFM192A | 46.0 | female | NA | NA | positive | negative | positive | derived from metastatic site:pleural effusion | adenocarcinoma |
| EVSAT | NA | female | NA | NA | negative | discordant | discordant | derived from metastatic site:ascitic effusion | carcinoma |
| HCC1143 | 52.0 | female | White | epithelial | negative | negative | negative | mammary gland;duct | ductal carcinoma |
| HCC1187 | 41.0 | female | White | epithelial | negative | negative | negative | breast | ductal carcinoma |
| HCC1395 | 43.0 | female | White | epithelial;lymphoblast | negative | negative | negative | breast;duct | ductal carcinoma |
| HCC1419 | 42.0 | female | Hispanic | epithelial | discordant | negative | positive | breast | ductal carcinoma |
| HCC1428 | 49.0 | female | White | epithelial | positive | positive | negative | derived from metastatic site:adenocarcinoma and pleural effusion | adenocarcinoma |
| HCC1500 | 32.0 | female | Black | epithelial | discordant | discordant | negative | gland;duct | ductal carcinoma |
| HCC1569 | 70.0 | female | African American | epithelial | negative | negative | positive | breast | metaplastic carcinoma |
| HCC1599 | 44.0 | female | White | epithelial;lymphoblast | negative | negative | negative | breast;duct | ductal carcinoma |
| HCC1806 | 60.0 | female | Black | epithelial | negative | negative | negative | breast | acantholytic squamous cell carcinoma |
| HCC1937 | 23.0 | female | White | epithelial;lymphoblast | negative | negative | negative | breast;duct | ductal carcinoma |
| HCC1954 | 61.0 | female | East Indian | epithelial | negative | negative | positive | breast;duct | ductal carcinoma |
| HCC202 | 82.0 | female | White | epithelial | negative | negative | positive | gland;duct | ductal carcinoma |
| HCC2157 | 48.0 | female | African American | epithelial | negative | positive | positive | gland;breast | ductal carcinoma |
| HCC2218 | 38.0 | female | White | epithelial;lymphoblast | negative | negative | positive | breast;duct | ductal carcinoma |
| HCC38 | 50.0 | female | White | epithelial | negative | negative | negative | breast;duct | ductal carcinoma |
| HCC70 | 49.0 | female | African American | epithelial | negative | negative | negative | breast;duct | ductal carcinoma |
| HDQP1 | 50.0 | female | White | NA | negative | negative | negative | primary | ductal carcinoma |
| HMC18 | NA | female | Japanese | NA | negative | NA | negative | metastasis | carcinoma |
| HMEL | NA | NA | NA | NA | NA | NA | NA | engineered breast | in situ |
| HS274T | NA | female | White | NA | NA | NA | NA | fibroblast | NA |
| HS578T | 74.0 | female | White | epithelial | negative | negative | negative | breast | carcinoma |
| JIMT1 | 62.0 | female | NA | NA | negative | negative | positive | metastasis | ductal carcinoma |
| KPL1 | NA | female | White | NA | positive | negative | negative | derived from metastatic site:pleural effusion | ductal carcinoma |
| MCF7 | 69.0 | female | White | epithelial | positive | positive | negative | derived from metastatic site:pleural effusion | adenocarcinoma |
| MDAMB134VI | 47.0 | female | White | epithelial | positive | NA | negative | derived from metastatic site:pleural effusion | ductal carcinoma |
| MDAMB157 | 44.0 | female | African American | epithelial | negative | negative | negative | breast;medulla | medulallary carcinoma |
| MDAMB175VII | 56.0 | female | African American | epithelial | positive | NA | negative | derived from metastatic site:pleural effusion | ductal carcinoma |
| MDAMB231 | 51.0 | female | White | epithelial | negative | negative | negative | derived from metastatic site:pleural effusion | adenocarcinoma |
| MDAMB330 | 43.0 | female | White | epithelial | positive | negative | positive | derived from metastatic site:pleural effusion | infiltrating lobular carcinoma |
| MDAMB361 | 40.0 | female | White | epithelial | positive | NA | positive | derived from metastatic site:brain | adenocarcinoma |
| MDAMB415 | 38.0 | female | White | NA | positive | NA | negative | derived from metastatic site:pleural effusion | adenocarcinoma |
| MDAMB436 | 43.0 | female | White | NA | negative | negative | negative | derived from metastatic site:pleural effusion | adenocarcinoma |
| MDAMB453 | 48.0 | female | White | epithelial | negative | negative | positive | derived from metastatic site:pericardial effusion | metastatic carcinoma |
| MDAMB468 | 51.0 | female | Black | epithelial | negative | negative | negative | derived from metastatic site:pleural effusion | adenocarcinoma |
| MFM223 | NA | female | NA | NA | negative | negative | negative | metastasis | NA |
| MRKNU1 | NA | female | Japanese | NA | negative | NA | negative | breast | carcinoma |
| OCUBM | NA | female | Japanese | NA | negative | negative | NA | breast | carcinoma |
| SKBR3 | 43.0 | female | White | epithelial | negative | negative | positive | derived from metastatic site:pleural effusion | adenocarcinoma |
| SUM149PT | NA | NA | NA | NA | negative | negative | negative | NA | ductal carcinoma |
| SUM159PT | NA | NA | NA | NA | negative | negative | negative | NA | anaplastic carcinoma |
| SUM229PE | NA | NA | NA | NA | negative | negative | negative | derived from metastatic site:pleural effusion | NA |
| T47D | 54.0 | female | NA | epithelial | positive | positive | negative | derived from metastatic site:pleural effusion | ductal carcinoma |
| UACC812 | 43.0 | female | NA | epithelial | discordant | negative | positive | breast | ductal carcinoma |
| UACC893 | 57.0 | female | White | epithelial | negative | negative | positive | breast | ductal carcinoma |
| YMB1E | NA | NA | NA | NA | NA | NA | NA | breast | ductal carcinoma |
| ZR751 | 63.0 | female | White | epithelial | positive | positive | negative | derived from metastatic site:ascites | ductal carcinoma |
| ZR7530 | 47.0 | female | African American | epithelial | positive | negative | positive | derived from metastatic site:ascites | ductal carcinoma |